polycystic ovarian syndrome
Conditions
Interventions
experimental group 1 :
experimental group 2:metformin
Sponsors
Ningxia Medical University General Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Obese PCOS patients
Exclusion criteria
Exclusion criteria: Menstruation that has been examined for reproductive organ organic lesions, such as congenital dysplasia of the uterus; Having adrenal cortical hyperplasia syndrome, thyroid disease or tumor; Functional uterine bleeding; Patients with primary diabetes and endocrine disorders; Hyperandrosteremia caused by other causes; Patients participating in other clinical trials; The combination has serious heart, liver, lung, kidney, brain and hematopoietic system and other primary disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hepatorenal function;Routine blood;blood lipid;Hypersensitive c-reactive protein;The six hormones;B ultrasonic for Gynecological examinations;AMH;stool routine test;intestinal flora;inflammatory factor; | — |
Countries
China
Contacts
Public ContactXiaorong LI
Ningxia Medical University General Hospital
Outcome results
None listed